Are Supplements Regulated by the FDA?

Dietary supplements — including protein powders, vitamins, herbal extracts, and sports nutrition products — occupy a distinct legal category in the United States. They are regulated by the Food and Drug Administration, but the framework that governs them is fundamentally different from the one that governs pharmaceutical drugs. Understanding that difference is central to understanding what any supplement label actually guarantees.

The law that defines dietary supplement regulation is the Dietary Supplement Health and Education Act of 1994, universally abbreviated as DSHEA. That single statute shapes what manufacturers must do before a product reaches store shelves, what claims they are permitted to make, and what authority the FDA holds once a product is already on the market. The gap between public expectation and what the law actually requires is wide, and it starts with one foundational distinction: supplements are not approved by the FDA before they are sold.

How Dietary Supplement Regulation Actually Works Under DSHEA

Under DSHEA, a dietary supplement is defined as a product intended to supplement the diet that contains a dietary ingredient — a vitamin, mineral, herb, amino acid, or similar substance. Protein supplements built from whey, casein, soy, or egg fall into this category, as do creatine, fish oil, and botanical extracts. The category is broad by design.

The most consequential feature of DSHEA is where the burden of proof sits. For a prescription drug, the manufacturer must demonstrate safety and efficacy to the FDA before the product can be sold. For a dietary supplement, the burden is reversed: the FDA must demonstrate that a product is unsafe before it can take enforcement action to remove it. The manufacturer does not submit clinical trial data for pre-market approval. It does not receive an FDA approval letter. It simply ensures — internally — that the product is safe and that its labeling complies with the law.

There is one partial exception. If a manufacturer wants to use a "new dietary ingredient" — one not marketed in the U.S. before October 15, 1994 — it must submit a notification to the FDA at least 75 days before marketing the product. That notification is not an approval process; the FDA reviews it but does not formally approve or reject the ingredient. It is closer to a disclosure requirement than a gatekeeping mechanism.

Once a product is on the market, the FDA's enforcement tools include issuing warning letters, requesting recalls, and pursuing legal action. The agency also monitors adverse event reports, which manufacturers of dietary supplements are required to submit when a serious adverse event is associated with their product. This post-market surveillance system is reactive rather than preventive, which is a structural feature of the regulatory framework, not an oversight.

The Agencies, Standards, and Bodies Involved in Supplement Oversight

The FDA is the primary federal agency overseeing dietary supplements, operating through its Center for Food Safety and Applied Nutrition (CFSAN). CFSAN enforces the Current Good Manufacturing Practice (cGMP) regulations that govern how supplements are manufactured, packaged, labeled, and stored. These cGMP rules, finalized in 2007, require manufacturers to establish identity, purity, strength, and composition of their products — meaning a protein powder must actually contain what its label says it contains, in the amounts stated.

The Federal Trade Commission (FTC) shares jurisdiction over the supplement industry, specifically regarding advertising. While the FDA governs product labeling, the FTC governs how products are marketed in commercials, online ads, and promotional content. The FTC requires that advertising claims be truthful and substantiated by competent and reliable scientific evidence. The two agencies operate under a memorandum of understanding that divides this oversight responsibility.

Beyond federal agencies, third-party testing organizations — independent bodies not affiliated with the FDA — offer voluntary certification programs. These programs test products for label accuracy, contaminants, and in some cases banned substances. A product that carries one of these seals has been verified by that organization against its own standards, but the seal does not represent FDA approval or government certification of any kind. The distinctions between these layers of oversight are explained in more detail in the context of how third-party supplement testing actually works.

State attorneys general also play a role. Several states have pursued enforcement actions against supplement companies for mislabeling or adulteration independently of federal action, adding a layer of oversight that varies by jurisdiction.

Where Dietary Supplement Regulation Breaks Down or Surprises People

The most common misconception about dietary supplement regulation is that an FDA-regulated product is an FDA-approved product. These are not the same thing. A supplement can be fully legal, manufactured in an FDA-registered facility, and compliant with cGMP rules, and still have never been reviewed by any government scientist for effectiveness or even for the accuracy of its label claims. Regulation in this context means the FDA has authority over the category — it does not mean the FDA has verified each product.

cGMP compliance is itself an area where the gap between requirement and reality surfaces. The FDA conducts inspections of supplement manufacturing facilities, but it does not inspect every facility every year, and the supplement industry is large. Inspections that identify violations result in warning letters, but the process of remediation can be slow. Independent analyses of supplements — including protein powders — have repeatedly found discrepancies between labeled and actual ingredient amounts, as well as the presence of undisclosed substances. This is not a theoretical risk; it is a documented pattern.

Label claims are also a regulated but frequently misunderstood area. Under DSHEA, a supplement may make a "structure/function claim" — a statement that a nutrient supports a normal body function, such as "protein supports muscle maintenance." It may not make a disease claim — a statement that the product diagnoses, treats, cures, or prevents a disease. The line between these two categories is not always obvious, and the FDA has issued extensive guidance on where it falls. Structure/function claims must be accompanied by a disclaimer stating that the FDA has not evaluated the claim and that the product is not intended to diagnose, treat, cure, or prevent any disease.

For protein supplements specifically, the regulatory framework interacts with manufacturing chemistry in ways that affect what a label can accurately represent. The process by which a whey isolate is made from milk involves filtration steps that alter protein concentration and remove lactose and fat — but the final protein percentage stated on the label depends on the nitrogen-based measurement method used, which can be influenced by non-protein nitrogen sources. cGMP rules require accurate labeling, but they do not specify which analytical method must be used for every ingredient.

The broader picture of how the supplement industry is actually regulated reveals a system that relies heavily on manufacturer self-compliance, with government enforcement functioning as a corrective mechanism after problems emerge rather than a preventive screen before products reach consumers.

What a Supplement Label and Certification Actually Show — and What They Do Not

A dietary supplement label is required by law to include a Supplement Facts panel listing serving size, the dietary ingredients present, and their amounts per serving. It must identify the product as a dietary supplement, list all ingredients, and include the name and address of the manufacturer or distributor. These are minimum disclosure requirements, not quality guarantees.

The presence of an FDA-registered facility address on a label means the manufacturer has registered with the FDA as required by law — it does not mean the facility has been inspected or approved. The presence of a cGMP logo on a label means the manufacturer claims to follow current good manufacturing practices — it does not mean a government agency has verified that claim through a recent inspection.

A third-party certification seal — from an independent testing organization — means that organization tested a sample of that product against its own published standards at a point in time. What it confirms depends on the scope of the program: some verify label accuracy for key ingredients, some screen for heavy metals or microbial contamination, some test for substances banned in competitive sport. None of these seals represent FDA approval, and none guarantee that every batch of the product performs identically to the tested sample.

Structure/function claims on labels — such as statements about protein supporting muscle tissue — must be accompanied by the standard disclaimer that the FDA has not evaluated the claim. Disease claims are prohibited. If a label states or strongly implies that a product treats or prevents a medical condition, that product is being marketed illegally under DSHEA and may be subject to FDA enforcement action.

What no label shows: pre-market clinical efficacy data reviewed by a government agency, confirmed bioavailability in the population using the product, or a guarantee that the product's composition will remain identical across future production batches.

The regulatory architecture for dietary supplements in the United States is real, specific, and consequential — and it is also structurally different from the pre-market approval system that governs pharmaceuticals. DSHEA created a framework in which manufacturers bear primary responsibility for safety and accuracy, the FDA acts as an enforcer rather than a pre-market gatekeeper, and third-party verification fills gaps that federal oversight does not cover by design.

Note: This explains how supplements work. This statement has not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for advice from a physician, pharmacist, or registered dietitian.